Home ›
Organizations ›
OXALOSIS AND HYPEROXALURIA FOUNDATION
OXALOSIS AND HYPEROXALURIA FOUNDATION
NY · Disease Research · EIN 911457505
1
Executives Disclosed
$1.6M
Annual Revenue
$6.9M
Total Assets
OXALOSIS AND HYPEROXALURIA FOUNDATION has 1 executive with disclosed compensation. The highest-paid executive, Kim Hollander (Executive Director), received peak total compensation of $259,082. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Kim Hollander | Executive Director | $259K | $253K | 2016–2024 | 3.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $171K | $171K | $171K |
| 2017 | 1 | $174K | $174K | $174K |
| 2018 | 1 | $204K | $204K | $204K |
| 2019 | 1 | $190K | $190K | $190K |
| 2020 | 1 | $200K | $200K | $200K |
| 2021 | 1 | $259K | $259K | $259K |
| 2022 | 1 | $208K | $208K | $208K |
| 2023 | 1 | $221K | $221K | $221K |
| 2024 | 1 | $253K | $253K | $253K |
Email Alerts
Get notified about OXALOSIS AND HYPEROXALURIA FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.